Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,286 | 576 | 98.6% |
| Education | $128.33 | 3 | 1.0% |
| Entertainment | $49.15 | 1 | 0.4% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,791 | 147 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $1,714 | 15 | $0 (2024) |
| Janssen Biotech, Inc. | $934.80 | 57 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $739.47 | 42 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $677.32 | 39 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $505.26 | 14 | $0 (2024) |
| PFIZER INC. | $439.51 | 18 | $0 (2022) |
| Allergan, Inc. | $334.76 | 26 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $289.27 | 4 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $284.29 | 27 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,876 | 66 | ABBVIE INC. ($556.56) |
| 2023 | $1,499 | 62 | AbbVie Inc. ($380.05) |
| 2022 | $1,774 | 70 | ABBVIE INC. ($364.76) |
| 2021 | $792.35 | 18 | Janssen Scientific Affairs, LLC ($230.49) |
| 2020 | $409.17 | 19 | Janssen Scientific Affairs, LLC ($110.42) |
| 2019 | $1,858 | 84 | AbbVie, Inc. ($410.31) |
| 2018 | $1,919 | 112 | AbbVie, Inc. ($359.36) |
| 2017 | $2,336 | 153 | AbbVie, Inc. ($511.58) |
All Payment Transactions
584 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $140.14 | General |
| Category: Immunology | ||||||
| 11/07/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $7.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $23.47 | General |
| Category: Neuroscience | ||||||
| 10/08/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/30/2024 | Johnson & Johnson Health Care Systems Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $129.02 | General |
| Category: Immunology | ||||||
| 09/26/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $22.75 | General |
| Category: GI | ||||||
| 09/19/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/12/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: ONCOLOGY | ||||||
| 09/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Gastroenterology | ||||||
| 09/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: Immunology | ||||||
| 08/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: IMMUNOLOGY | ||||||
| 08/15/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Rare Disease | ||||||
| 08/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: IMMUNOLOGY | ||||||
| 08/06/2024 | Braintree Laboratories, Inc. | SUFLAVE (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: GI COLON PREP | ||||||
| 08/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: IMMUNOLOGY | ||||||
| 08/05/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $6.30 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 803 | 827 | $514,917 | $98,570 |
| 2022 | 15 | 776 | 819 | $492,620 | $96,237 |
| 2021 | 11 | 806 | 847 | $466,472 | $97,953 |
| 2020 | 15 | 752 | 782 | $388,258 | $80,858 |
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 189 | 190 | $202,730 | $38,693 | 19.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 139 | 151 | $32,767 | $13,336 | 40.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 55 | 55 | $42,796 | $9,755 | 22.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 139 | 139 | $94,520 | $8,340 | 8.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 69 | 69 | $58,443 | $7,464 | 12.8% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 31 | 31 | $24,211 | $5,417 | 22.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 76 | 78 | $11,544 | $5,120 | 44.3% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 30 | 32 | $22,432 | $3,352 | 14.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $7,636 | $2,715 | 35.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 23 | 23 | $5,037 | $1,751 | 34.8% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 15 | 15 | $9,735 | $1,330 | 13.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 21 | $3,066 | $1,298 | 42.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 115 | 115 | $122,705 | $22,428 | 18.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 207 | 240 | $52,080 | $20,048 | 38.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 48 | 48 | $37,353 | $8,559 | 22.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 64 | 64 | $54,208 | $8,386 | 15.5% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2022 | 13 | 13 | $48,815 | $7,974 | 16.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 124 | 124 | $82,252 | $6,665 | 8.1% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 32 | 32 | $24,992 | $5,744 | 23.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 49 | 49 | $16,268 | $5,694 | 35.0% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 23 | 24 | $16,824 | $2,357 | 14.0% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 16 | 16 | $11,950 | $1,941 | 16.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 18 | 18 | $5,004 | $1,783 | 35.6% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 17 | 17 | $11,033 | $1,615 | 14.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 24 | $3,552 | $1,294 | 36.4% |
About Dr. David Spady, M.D
Dr. David Spady, M.D is a Gastroenterology healthcare provider based in Southlake, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1639155005.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Spady, M.D has received a total of $12,464 in payments from pharmaceutical and medical device companies, with $1,876 received in 2024. These payments were reported across 584 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($12,286).
As a Medicare-enrolled provider, Spady has provided services to 3,137 Medicare beneficiaries, totaling 3,275 services with total Medicare billing of $373,618. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Southlake, TX
- Active Since 12/19/2005
- Last Updated 05/16/2013
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1639155005
Products in Payments
- STELARA (Biological) $2,350
- Humira (Biological) $784.31
- RINVOQ (Biological) $719.30
- XIFAXAN (Drug) $566.66
- OCALIVA (Drug) $462.72
- ENTYVIO (Biological) $456.35
- LINZESS (Drug) $348.10
- XELJANZ (Drug) $347.97
- ZEPOSIA (Drug) $334.06
- SKYRIZI (Biological) $321.21
- Creon (Drug) $298.66
- REMICADE (Biological) $279.15
- DUPIXENT (Biological) $264.98
- INJECTAFER (Drug) $258.40
- TRULANCE (Drug) $192.28
- VIBERZI (Drug) $191.98
- DIFICID (Drug) $184.16
- OMVOH (Drug) $177.71
- Entyvio (Biological) $175.72
- LINX Reflux Management System (Device) $161.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Southlake
Dr. Timothy Ritter, M.d, M.D
Gastroenterology — Payments: $1.1M
Dr. David Levitan, M.d, M.D
Gastroenterology — Payments: $26,370
Dr. James Weber, M.d, M.D
Gastroenterology — Payments: $17,582
Dr. Stephen Lacey, M.d, M.D
Gastroenterology — Payments: $5,636
Dr. Jeffrey Smith, M.d, M.D
Gastroenterology — Payments: $5,235
Dr. Azaan Ramani, Do, DO
Gastroenterology — Payments: $4,793